Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years ...

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the brain. Researchers at Case Western Reserve University found that people ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

Although there’s no proper cure for dementia, prevention is possible even from a young age. It’s the spotting of early signs of the disease that helps in preventing the disease with an early ...

New research suggests that dementia prevention should begin much earlier than previously thought—possibly as early as ...